Watch and Wait Approach Following Extended Neoadjuvant Chemoradiation for Distal Rectal Cancer: Are We Getting Closer to Anal Cancer Management?

Imagem de Miniatura
Arquivos
art_SABBAGA_Watch_and_Wait_Approach_Following_Extended_Neoadjuvant_Chemoradiation_2013.PDF (462.17 KB)
Citações na Scopus
378
Tipo de produção
article
Data de publicação
2013
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Autores
HABR-GAMA, Angelita
GAMA-RODRIGUES, Joaquim
JULIAO, Guilherme P. Sao
PROSCURSHIM, Igor
Citação
DISEASES OF THE COLON & RECTUM, v.56, n.10, p.1109-1117, 2013
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BACKGROUND: No immediate surgery (Watch and Wait) has been considered in select patients with complete clinical response after neoadjuvant chemoradiation to avoid postoperative morbidity and functional disorders after radical surgery. OBJECTIVE: The purpose of this study was to demonstrate the long-term results of patients who had a complete clinical response following an alternative chemoradiation regimen and were managed nonoperatively. DESIGN: This is a prospective study. SETTINGS: This study was conducted at a single center. PATIENTS: Seventy consecutive patients with T2-4N0-2M0 distal rectal cancer were studied. Neoadjuvant chemoradiotherapy included 54 Gy and 5-fluorouracil/leucovorin delivered in 6 cycles every 21 days. Patients were assessed for tumor response at 10 weeks from radiation completion. Patients with incomplete clinical response were referred to immediate surgery. Patients with complete clinical response were not immediately operated on and were monitored. MAIN OUTCOME MEASURES: The primary outcomes measured were the initial complete clinical response rates after 10 weeks and the sustained complete clinical response rates after 12 months from chemoradiotherapy. RESULTS: One patient died during chemoradiotherapy because of cardiac complications. Forty-seven (68%) patients had initial complete clinical response. Of these, 8 developed local regrowth within the first 12 months of follow-up (17%). Thirty-nine sustained complete clinical response at a median follow-up of 56 months (57%). An additional 4 patients (10%) developed late local recurrences (>12 months of follow-up). Overall, 35 patients never underwent surgery (50%). LIMITATIONS: This study is limited by the short follow-up and small sample size. CONCLUSION: Extended chemoradiation therapy with additional chemotherapy cycles and 54 Gy of radiation may result in over 50% of sustained (>12 months) complete clinical response rates that may ultimately avoid radical rectal resection. Local failures occur more frequently during the initial 12 months of follow-up in up to 17% of cases, whereas late recurrences are less common but still possible, leading to 50% of patients who never required surgery. Strict follow-up may allow salvage therapy in the majority of these patients (see Video, Supplemental Digital Content 1, http://links.lww.com/DCR/A113.)
Palavras-chave
Neoadjuvant chemoradiation, Rectal cancer, Watch and wait
URI
https://observatorio.fm.usp.br/handle/OPI/4004
Referências
  1. Dalton RSJ, 2012, COLORECTAL DIS, V14, P567, DOI 10.1111/j.1463-1318.2011.02752.x
  2. Das P, 2007, CANCER, V109, P1750, DOI 10.1002/cncr.22625
  3. Gerard JP, 2004, J CLIN ONCOL, V22, P2404, DOI 10.1200/JCO.2004.08.170
  4. Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376
  5. Glynne-Jones R, 2010, ACTA ONCOL, V49, P278, DOI 10.3109/02841860903536010
  6. Glynne-Jones R, 2008, DIS COLON RECTUM, V51, P10, DOI 10.1007/s10350-007-9080-8
  7. Habr-Gama A, 2008, INT J RADIAT ONCOL, V71, P1181, DOI 10.1016/j.ijrobp.2007.11.035
  8. Habr-Gama A, 2009, BRIT J SURG, V96, P125, DOI 10.1002/bjs.6470
  9. Habr-Gama A, 2006, J GASTROINTEST SURG, V10, P1319, DOI 10.1016/j.gassur.2006.09.005
  10. Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
  11. Habr-Gama A, 2010, DIS COLON RECTUM, V53, P1692, DOI 10.1007/DCR.0b013e3181f42b89
  12. Habr-Gama A, 2009, DIS COLON RECTUM, V52, P1927, DOI 10.1007/DCR.0b013e3181ba14ed
  13. Habr-Gama A, 2005, J GASTROINTEST SURG, V9, P90, DOI 10.1016/j.gassur.2004.10.010
  14. Kalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63
  15. Lambregts DMJ, 2011, DIS COLON RECTUM, V54, P1521, DOI 10.1097/DCR.0b013e318232da89
  16. Lambregts DMJ, 2011, ANN SURG ONCOL, V18, P2224, DOI 10.1245/s10434-011-1607-5
  17. Maas M, 2011, J CLIN ONCOL, V29, P4633, DOI 10.1200/JCO.2011.37.7176
  18. Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8
  19. Perez RO, 2012, CANCER-AM CANCER SOC, V118, P3501, DOI 10.1002/cncr.26644
  20. Quah HM, 2008, CANCER, V113, P57, DOI 10.1002/cncr.23516
  21. Restivo A, 2013, ANN SURG ONCOL, V20, P864, DOI 10.1245/s10434-012-2669-8
  22. Sanghera P, 2008, CLIN ONCOL-UK, V20, P176, DOI 10.1016/j.clon.2007.11.013

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - ODS/03